Related references
Note: Only part of the references are listed.Surgical Excision After Neoadjuvant Therapy With Vismodegib for a Locally Advanced Basal Cell Carcinoma and Resistant Basal Carcinomas in Gorlin Syndrome
Anne Lynn S. Chang et al.
JAMA DERMATOLOGY (2013)
Vismodegib and the Hedgehog Pathway: A New Treatment for Basal Cell Carcinoma
Frank Cirrone et al.
CLINICAL THERAPEUTICS (2012)
Intricacies of hedgehog signaling pathways: A perspective in tumorigenesis
Swayamsiddha Kar et al.
EXPERIMENTAL CELL RESEARCH (2012)
Multiple familial and pigmented basal cell carcinomas in early childhood - Bazex-Dupre-Christol syndrome
F. Abuzahra et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome
Jean Y. Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hedgehog pathway as a drug target: Smoothened inhibitors in development
Tara L. Lin et al.
ONCOTARGETS AND THERAPY (2012)
Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
Gerrit J. P. Dijkgraaf et al.
CANCER RESEARCH (2011)
Systemic therapy for disseminated basal cell carcinoma: An uncommon manifestation of a common cancer
Apar Kishor Ganti et al.
CANCER TREATMENT REVIEWS (2011)
Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
Patricia M. LoRusso et al.
CLINICAL CANCER RESEARCH (2011)
Phase I/II Study of Pemetrexed With or Without ABT-751 in Advanced or Metastatic Non-Small-Cell Lung Cancer
Charles M. Rudin et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Topical Treatment of Basal Cell Carcinomas in Nevoid Basal Cell Carcinoma Syndrome with a Smoothened Inhibitor
Hans Skvara et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Elucidating the Role of Molecular Signaling Pathways in the Tumorigenesis of Basal Cell Carcinoma
Jean Y. Tang
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2011)
Basal Cell Carcinomas in Gorlin Syndrome: A Review of 202 Patients
Elizabeth A. Jones et al.
JOURNAL OF SKIN CANCER (2011)
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
James Kim et al.
CANCER CELL (2010)
Cancer Stem Cells and Self-renewal
Catherine Adell O'Brien et al.
CLINICAL CANCER RESEARCH (2010)
The Role of the Hedgehog Signaling Pathway in the Development of Basal Cell Carcinoma and Opportunities for Treatment
Ivor Caro et al.
CLINICAL CANCER RESEARCH (2010)
Clinical Experience With Hedgehog Pathway Inhibitors
Jennifer A. Low et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma
Silvia Buonamici et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Context-dependent Regulation of the GLI Code in Cancer by HEDGEHOG and Non-HEDGEHOG Signals
Barbara Stecca et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2010)
Review: Targeting the Hedgehog pathway in cancer
Sachin Gupta et al.
Therapeutic Advances in Medical Oncology (2010)
GDC-0449-A potent inhibitor of the hedgehog pathway
Kirk D. Robarge et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Bazex-Dupre-Christol syndrome: An ectodermal dysplasia with skin appendage neoplasms
Marco Castori et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2009)
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
Chen Zhao et al.
NATURE (2009)
Brief Report: Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449.
Charles M. Rudin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma.
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mouse Kif7/Costal2 is a cilia-associated protein that regulates Sonic hedgehog signaling
Karel F. Liem et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch et al.
SCIENCE (2009)
Palliative therapy of giant basal cell carcinoma with the monoclonal anti-epidermal growth factor receptor antibody cetuximab
R. Mueller et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up
Klara Mosterd et al.
LANCET ONCOLOGY (2008)
Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL
Hagop Kantarjian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Negative regulation of Gli1 and Gli2 activator function by suppressor of fused through multiple mechanisms
PC Barnfield et al.
DIFFERENTIATION (2005)
Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas - Role of clinical features, microsatellite instability, and immunohistochemistry
G Ponti et al.
CANCER (2005)
Aggressive basal cell carcinoma: Presentation, pathogenesis, and management
HW Walling et al.
CANCER AND METASTASIS REVIEWS (2004)
Metastatic basal cell carcinoma: Rapid symptomatic response to cisplatin and paclitaxel
M Jefford et al.
ANZ JOURNAL OF SURGERY (2004)
Basal cell carcinoma
CSM Wong et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome
LL Wang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Nonmelanoma skin cancer in organ transplant patients
GBE Jemec et al.
TRANSPLANTATION (2003)
Mutations in SUFU predispose to medulloblastoma
MD Taylor et al.
NATURE GENETICS (2002)
A case of Rombo syndrome
MAM Van Steensel et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer
G Krahn et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
